Aberrant PI3K/AKT/mTOR signaling is also observed in pathological skin, in particular in cutaneous cancer, as well as in chronic inflammatory diseases, such as psoriasis and atopic dermatitis (AD). Here, AKT1 is linked to psoriasis.